Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CNL Healthcare Properties (CHTH) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for CNL Healthcare Properties (CHTH) over the last 13 years, with Q3 2025 value amounting to -$1.6 million.

  • CNL Healthcare Properties' Consolidated Net Income rose 4998.42% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.6 million, marking a year-over-year increase of 4298.02%. This contributed to the annual value of -$14.4 million for FY2024, which is N/A changed from last year.
  • CNL Healthcare Properties' Consolidated Net Income amounted to -$1.6 million in Q3 2025, which was up 4998.42% from -$1.5 million recorded in Q2 2025.
  • Over the past 5 years, CNL Healthcare Properties' Consolidated Net Income peaked at -$10000.0 during Q1 2021, and registered a low of -$9.1 million during Q4 2023.
  • Moreover, its 4-year median value for Consolidated Net Income was -$4.1 million (2024), whereas its average is -$3.8 million.
  • As far as peak fluctuations go, CNL Healthcare Properties' Consolidated Net Income crashed by 10255.1% in 2021, and later soared by 7565.43% in 2024.
  • CNL Healthcare Properties' Consolidated Net Income (Quarter) stood at -$10000.0 in 2021, then tumbled by 90910.0% to -$9.1 million in 2023, then soared by 45.61% to -$5.0 million in 2024, then surged by 68.12% to -$1.6 million in 2025.
  • Its Consolidated Net Income stands at -$1.6 million for Q3 2025, versus -$1.5 million for Q2 2025 and -$2.6 million for Q1 2025.